Brainsway's breakthrough
Deep TMS technology introduces:

A highly effective, clinically-proven and safe solution for Depression patients

  • Wide FDA indication for treating Major Depressive Disorder, including patients who failed to benefit from any number of antidepressant treatments*
  • Convenient outpatient treatment – No anesthesia or hospitalization; just 20-minute sessions over a course of 4 weeks
  • Safe - No long-term side effects, no systemic effects
  • Patented by the U.S. National Institutes of Health (NIH)
  • Over 60 clinical trials in leading institutions worldwide
* Brainsway Deep TMS System is indicated by the FDA for the treatment of depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode. 510(k) No. K122288.
Brainsway 2013 All Rights Reserved.
Email: info@brainsway.com | Tel: 1-855-200-DTMS | Fax: +972-2-581-2517
Address: 19 Hartum st. Bynet Building, Har Hotzvim, P.O. Box 45169, Jerusalem, Israel, 91451
Learn how Brainsway can help you or your patients!
Name: Email: Phone: State: Message:
Or Contact Us at:
info@brainsway.com
News
Visit us at the APA NYC, May 3-7, Booth 1345
For More Information
 

Brainsway's international website includes clinical and regulatory data for indications which were not cleared by the FDA for use in the United States.

This site is not intended for residents of the United States, its territories, and Puerto Rico.

The FDA cleared Brainsway's Deep TMS system for use in the U.S for treatment of depressive episodes in adult patients suffering from Major Depressive Disorder who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode.


Would you like to proceed to the international website? To proceed click here
or click here to close this window